New developments in antiretroviral treatment.
Sadovsky
R
R
D019380:Anti-HIV Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001682:Biological Availability; D017277:Drug Approval; D004347:Drug Interactions; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D011480:Protease Inhibitors / Q000493:pharmacokinetics / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000493:pharmacokinetics / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D019380:Anti-HIV Agents; D011480:Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors